The Spectranetics
The Spectranetics Corporation specializes in the development, manufacturing, and distribution of single-use medical devices for minimally invasive cardiovascular procedures. Its portfolio includes laser and aspiration catheters, scoring balloon catheters, and drug-coated balloon catheters, used to cross, prepare, and treat arterial blockages in the legs and heart. Additionally, the company offers products for the removal of pacemaker and defibrillator cardiac leads, and provides laser systems for various cardiovascular procedures. Spectranetics sells its products directly and through distributors worldwide, with a focus on innovation to meet the demands of complex cardiac lead removal and vascular intervention procedures. Headquartered in Colorado Springs, Colorado, the company operates as a subsidiary of Philips Holding USA Inc.
1 past transactions
AngioScore
Acquisition in 2014
AngioScore Inc. is a medical device company that specializes in the development, manufacturing, and marketing of innovative angioplasty catheters aimed at treating cardiovascular and vascular diseases. The company's flagship product, the AngioSculpt Scoring Balloon Catheter, is designed for use in both coronary and peripheral interventional markets. This device addresses the limitations of traditional angioplasty balloon catheters by integrating a semi-compliant balloon with a unique nitinol scoring element, enhancing the effectiveness of vascular interventions. AngioScore's focus on advancing endovascular therapy tools positions it as a key player in the medical device industry dedicated to improving patient outcomes in vascular treatments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.